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Abstract
Background: Mucous Membrane Pemphigoid (MMP) is a rare group of chronic autoimmune
disorders characterized by blister producing lesions. It is the variant most likely to occur in the oral
cavity and eyes. Few studies shows autoimmune bullous diseases associated with human
immunodeficiency virus (HIV).
Case presentation: oral blisters, painful ulcerations and eye symblepharon were observed in a
patient with HIV infection. The histopathologic exam showed a subepidermal blister and the overall
features were suggestive of MMP.
Conclusion: In this case, the MMP was associated with HIV. Interactions with the immune system
may lead to the development of this autoimmune process.
Background
Mucous membrane pemphigoid (MMP), new denomina-
tion of cicatricial pemphigoid [1,2] encompasses a group
of chronic subepithelial autoimmune blistering diseases
that predominantly affect the mucous membranes with
potential scar formation. This is a rare condition and few
studies shows autoimmune bullous diseases associated
with human immunodeficiency virus (HIV). We report
the case of a patient with HIV infection who developed
mucous membrane pemphigoid in the absence of any
other HIV-related clinical conditions that is, to our knowl-
edge, the first description in the medical literature.
Case presentation and discussion
A 48-year-old man diagnosed with HIV infection 13 years
earlier, was presented with tense oral blisters and painful
ulcerations associated with 15 days' duration. He had no
history of skin or genital erosions. The patient showed no
symptoms of HIV-related illnesses and never used antiret-
roviral therapy. Your last CD4 count was 1970/mL.
The patient was not taking any other prescription or alter-
native medicines. During the past 2 years, he experienced
7 episodes of intense pain and burn in buccal mucosa,
including the present episode of bullous lesions. On oral
examination, he had few well-defined erosions involving
mouth and a small blister (Fig 1a). In his left eye its pos-
sible to see a mild conjunctivitis and symblepharon for-
mation (Fig 1b). Nikolsky sign on buccal mucosa were
positive.
The histopathologic exam of perilesional tissue showed
on a subepidermal blister with an inflammatory infiltrate
in the upper dermis composed of lymphocytes and eosi-
nophilic leucocytes (Fig 2).
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pemphigoid. In the absence of immunofluorescence stud-
ies, in this case, the diagnosis was firmly based on a classic
clinical presentation of MMP: severe vesicles, erosions and
crusts on mucous membranes, typically affecting the oral
cavity and eyes [3]. A direct immunofluorescence test
could not be done because the patient was a prisoner and
the pathology laboratory of the prison camp does not
have the necessary technology for immunofluorescence
studies.
The possibility of a drug-induced bullous eruption was
effectively excluded in this patient because did not use any
drugs. In this prison exists a specific set for patients in
medical observation. In this local, the patient stay isolated
alone, and he is reviewed before entering in this place, so
that the specified treatment can be appropriately made.
He was treated with topical corticosteroids and informed
about oral hygiene care. Within 2 weeks of treatment, he
had significantly improved with almost complete disap-
pearance of the lesions. A few small, tense vesicles contin-
ued to appear eventually.
Oral corticosteroid therapy in HIV-infected individuals
raises concern regarding increased immunosuppression,
therefore it should not be used in continuous treatment.
Autoimmune bullous diseases in oral cavity associated
with human immunodeficiency virus (HIV) infection are
extremely rare and illustrates that patients with HIV are
capable of mounting organ-specific autoantibody-medi-
ated diseases [4-7].
Molecular mimicry is one of the proposed mechanisms in
the development of autoimmune disease in HIV patients.
The exogenous infectious agent may have molecular sim-
ilarity to a self-antigen and may therefore induce an
autoimmune response [8].
Immune deregulation secondary to HIV infection may
lead to increased risk of developing an autoimmune dis-
ease. Development of autoantibodies may be part of the
nonspecific polyclonal B-cell stimulation seen in early
stages of HIV infection secondary to interleukin (IL)-1 and
IL-2 release by HIV-infected macrophages [9].
On the other hand, the loss of specific immunomodula-
tory CD4 T cells may allow the expansion of the B-cell
clone responsible for the autoantibody formation [7].
Immunodeficiency and autoimmunity seem to be the two
opposite sides of the spectrum of the clinical immune
response. However, persistent antigen stimulation, due to
an inherently defective immune system ability to eradi-
cate pathogenesis is the primary cause leading to autoim-
munity in patients with immunodeficiency states [10].
Conclusion
This case and others of autoimmune bullous diseases in
association with HIV illustrated on literature showed that
HIV might have varying interactions with the immune sys-
(a) A man with HIV presenting oral blister and erosions; (b) symblepharon formation on eyeFigur  1
(a) A man with HIV presenting oral blister and ero-
sions; (b) symblepharon formation on eye.
Subepidermal bullaeFigure 2
Subepidermal bullae. Dermis shows perivascular inflam-
matory infiltrates containing eosinophils and neutrophils (HE, 
original magnification ×100).Page 2 of 3
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tem, which may lead to the development of autoimmune
processes.
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